These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 29625129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H, Zhang T, Pan F, Steer CJ, Li Z, Chen X, Song G.
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
    Wu H, Ng R, Chen X, Steer CJ, Song G.
    Gut; 2016 Nov; 65(11):1850-1860. PubMed ID: 26282675
    [Abstract] [Full Text] [Related]

  • 4. LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression.
    Zhang T, Duan J, Zhang L, Li Z, Steer CJ, Yan G, Song G.
    Hepatology; 2019 Apr; 69(4):1488-1503. PubMed ID: 30281809
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.
    Zhang T, Hu J, Wang X, Zhao X, Li Z, Niu J, Steer CJ, Zheng G, Song G.
    J Hepatol; 2019 Jan; 70(1):87-96. PubMed ID: 30218679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W, Lee JH, Kim SW, Kim JH, Bae SH, Kim M, Hwang D, Kim YS, Park T, Um SJ, Song BJ, Yoon SK.
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
    Xiao J, Bei Y, Liu J, Dimitrova-Shumkovska J, Kuang D, Zhou Q, Li J, Yang Y, Xiang Y, Wang F, Yang C, Yang W.
    J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
    Wang XY, Lu LJ, Li YM, Xu CF.
    Life Sci; 2022 Nov 01; 308():120925. PubMed ID: 36057399
    [Abstract] [Full Text] [Related]

  • 14. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
    Liu Y, Zhou X, Xiao Y, Li C, Huang Y, Guo Q, Su T, Fu L, Luo L.
    J Endocrinol; 2020 Jun 01; 245(3):411-423. PubMed ID: 32252024
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of microRNA-367 promotes liver steatosis through repressing TBL1 in obese mice.
    Li DD, Liu Y, Xue L, Su DY, Pang WY.
    Eur Rev Med Pharmacol Sci; 2017 Apr 01; 21(7):1598-1603. PubMed ID: 28429344
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS, Kim SG, Kim YS, Jang SH, Kwon Y, Choi D, Huh T, Moon E, Ahn E, Seong JK, Kweon HS, Hwang GS, Lee DH, Cho KW, Koo SH.
    Mol Metab; 2022 Jan 01; 55():101402. PubMed ID: 34838715
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.
    Lei L, Zhou C, Yang X, Li L.
    Clin Exp Pharmacol Physiol; 2018 Aug 01; 45(8):819-831. PubMed ID: 29569260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.